Ira Scott Greenspan - 19 Aug 2021 Form 4 Insider Report for Scopus BioPharma Inc.

Signature
/s/ Ira Scott Greenspan
Issuer symbol
SCPS on OTC
Transactions as of
19 Aug 2021
Net transactions value
+$9,772
Form type
4
Filing time
23 Aug 2021, 08:24:04 UTC
Previous filing
19 Aug 2021
Next filing
25 Aug 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCPS Common Stock, par value $0.001 Purchase $8,080 +2,000 +17% $4.04* 13,850 19 Aug 2021 HCFP F1, F2
transaction SCPS Common Stock, par value $0.001 Purchase $1,692 +400 +0.49% $4.23* 81,790 20 Aug 2021 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.02 to $4.10 per share inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.
F2 Mr. Greenspan is deemed to have shared voting and dispositive power over HCFP-held securities. Mr. Greenspan disclaims beneficial ownership of shares by this entity, except to the extent of his proportionate pecuniary interest therein.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.22 to $4.25 per share inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4.